Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: A case-control study

Internal Medicine Journal

Volumn 35, Issue 3, 2005, Pages 188-190

  Lin, M S ^a,b   Dai, Y S ^b   Pwu, R F ^c   Chen, Y H ^b   Chang, Nen Chung ^d,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c iSTAT Healthcare Consulting Co Ltd   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adverse drug reaction; Case control study; Relative risk; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAMAZEPINE; CEFADROXIL; CEFAZOLIN; CEFOTIAM; CEPHALOSPORIN; CHLORZOXAZONE; LINCOMYCIN; MELOXICAM; METHOTREXATE; NABUMETONE; NAPROXEN; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; TEGAFUR; TENOXICAM; TIAPROFENIC ACID;

ARTICLE; CALCULATION; CASE CONTROL STUDY; DISEASE ASSOCIATION; DRUG SAFETY; EXPERIENCE; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADULT; ALLOPURINOL; ANALGESICS, NON-NARCOTIC; ANTICONVULSANTS; ANTIMETABOLITES; CARBAMAZEPINE; CASE-CONTROL STUDIES; DRUG THERAPY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENYTOIN; RISK ASSESSMENT; STEVENS-JOHNSON SYNDROME; TAIWAN;

EID: 15244341936     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00790.x     Document Type: Article

References (18)

1. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-7.
2. Huff JC. Erythema multiforme. In: Sams WM, Lynch PJ, eds. Principles and Practice of Dermatology, 2nd edn. New York: Churchill Livingstone; 1996; 483-90.
3. Fritsch PO, Ruiz-Maldonado R. Erythema multiforme. In: Freedberg IM, Eisen AZ, Wolff K et al. eds. Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill; 1999, 636-44.
4. Rzany B, Correia O, Kelly J, Naldi L, Anquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet 1999; 353: 2190-4.
5. Chou BL, Chou CT, Lee CF. A clinical analysis of the Stevens-Johnson syndrome. J Med Sci 1988; 9: 131-8.
6. Schöpf E, Stühmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 1991; 127: 839-42.
7. Li TH, Chan YC, Sun CC. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis - antecedent drug exposures in 99 hospitalized patients. Dermatol Sinica 1996; 14: 119-25.
8. Fritsch PO, Ruiz-Maldonado R. Stevens-Johnson syndrome - toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K et al. eds. Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill; 1999; 644-54.
9. Practice Management Information Corporation. International Classification of Diseases. 9th revision. Clinical Modification, 6th edn. Los Angeles: PMIC; 2001; 391.
10. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 1990; 126: 43-7.
11. Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S, Correia O et al. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 1995; 48: 1099-108.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
13. Rzany B, Mockenhaupt M, Baur S, Schroder W, Stocker U, Mueller J et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol 1996; 49: 769-73.
14. Steven KH, Kenneth HK, Teri HB, Kirsten KN, Wendy LB, Sara LS et al. eds. Facts and Comparisons: Drug Facts and Comparisons, 55th edn. St. Louis: Facts and Comparisons; 2001; 377-9.
15. Steven KH, Kenneth HK, Teri HB, Kirsten KN, Wendy LB, Sara LS et al. eds. Facts and Comparisons: Drug Facts and Comparisons, 55th edn. St. Louis: Facts and Comparisons; 2001; 1028-9.
16. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M et al. A population-based study of Stevens-Johnson syndrome. Arch Dermatol 1991; 127: 831-8.
17. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Stolley PD et al. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 1991; 10: 565-76.
18. Steven KH, Kenneth HK, Teri HB, Kirsten KN, Wendy LB, Sara LS et al. eds. Facts and Comparisons: Drug Facts and Comparisons, 55th edn. St. Louis: Facts and Comparisons; 2001; 1039-42.